SCHEMBL23625932

SCHEMBL23625932

COC(=O)c1cc2cc3c(cc2cc1N)OCO3

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.65
ALDH1A1 P00352 8/20 0.65
GAA P10253 6/20 0.45
MAPT P10636 4/20 0.45
HPGD P15428 4/20 0.45
HSD17B10 Q99714 4/20 0.45
CASP1 P29466 2/20 0.45
CASP7 P55210 2/20 0.45
ATM Q13315 2/20 0.45
GLA P06280 2/20 0.45
ABL1 P00519 1/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
TSHR P16473 3/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30952894 1.00 KDM4E (0.65) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL30952932 1.00 KDM4E (0.65) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL30952930 0.91 KDM4E (0.79) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL23625923 0.91 KDM4E (0.79) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL30952885 0.91 KDM4E (0.79) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL31324803 0.89 KDM4E (0.81) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL5666716 0.89 KDM4E (0.81) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL24824319 0.88 KDM4E (0.70) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL24961374 0.87 KDM4E (0.73) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL30041634 0.87 KDM4E (0.73) KDM4EALDH1A1GAAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230021669-A1 TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF The National Institutes of Pharmaceutical R&D Co., Ltd. (CN) 2023-01-26 US disclosed
WO-2021136244-A1 TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 中国医药研究开发中心有限公司 2021-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230021669-A1 TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF CYP4A11, CYP4F11, CYP11B2 KDM4E 4270/4885ALDH1A1 50/4885GAA 693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.